Merck KGaA (FRA:MRK) has been given a €116.00 ($128.89) price objective by investment analysts at Warburg Research in a research report issued to clients and investors on Tuesday. The firm presently has a “neutral” rating on the healthcare company’s stock.

MRK has been the topic of a number of other reports. Morgan Stanley set a €103.00 ($114.44) target price on shares of Merck KGaA and gave the stock a “neutral” rating in a research report on Tuesday, February 21st. BNP Paribas set a €114.00 ($126.67) price objective on shares of Merck KGaA and gave the company a “buy” rating in a research report on Tuesday, February 28th. Deutsche Bank AG set a €118.00 ($131.11) price objective on shares of Merck KGaA and gave the company a “buy” rating in a research report on Monday, February 20th. Citigroup Inc. set a €116.00 ($128.89) price objective on shares of Merck KGaA and gave the company a “buy” rating in a research report on Wednesday, March 1st. Finally, J P Morgan Chase & Co reissued a “neutral” rating on shares of Merck KGaA in a research report on Monday, February 27th. One research analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and seven have given a buy rating to the company. Merck KGaA has an average rating of “Hold” and a consensus price target of €110.14 ($122.37).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Merck KGaA (MRK) opened at 108.70 on Tuesday. Merck KGaA has a 52-week low of €80.99 and a 52-week high of €115.00. The company’s 50 day moving average is €108.14 and its 200-day moving average is €103.45. The company has a market capitalization of €47.19 billion and a price-to-earnings ratio of 30.30.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/06/20/warburg-research-analysts-give-merck-kgaa-mrk-a-116-00-price-target.html.

Merck KGaA Company Profile

.

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.